Here are four points:
1. CG Asset Management owns around 0.11 percent of NuVasive, worth $2.9 million.
2. NuVasive has a 50-day moving average of $42.88 and a 200-day moving average of $49.16.
3. The company has a 12-month low of $36.81 and a 12-month high of $56.61.
4. The company has a market cap of $2.34 billion.
More articles on devices:
28 orthopedic & spine devices receive FDA 510(k) clearance in February
Medtech sells 3 ROSA Brain Systems in US, China — 4 points
Mayo Clinic researchers develop expandable polymer grafts — 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
